These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 573499)

  • 1. Evaluation of immunocompetence and "immunostaging".
    Ablin RJ; Guinan PD; Khin W; Zamora S
    South Med J; 1979 Oct; 72(10):1350-1. PubMed ID: 573499
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunostaging: comment and update.
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(6):685-8. PubMed ID: 7193968
    [No Abstract]   [Full Text] [Related]  

  • 3. Genitourinary tumors and immunology.
    Lange PH
    Proc Inst Med Chic; 1978; 32(4):58-9. PubMed ID: 86188
    [No Abstract]   [Full Text] [Related]  

  • 4. [Theoretical and practical possibilities of immunotherapy in malignant urologic tumors].
    Adolphs HD; Steffens L
    Helv Chir Acta; 1976 Jul; 43(3):285-93. PubMed ID: 780321
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifactorial immunological treatment of cancer in urology.
    Reuter HJ
    Helv Chir Acta; 1976 Jul; 43(3):279-83. PubMed ID: 947866
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy for genitourinary malignancies in the here and now!
    Slovin SF
    Urol Oncol; 2016 Apr; 34(4):169-70. PubMed ID: 26705103
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: "immunostaging" patients with malignant disease.
    Guinan PD; Ablin RJ; Bruns GR; Bush IM
    Urology; 1974 Dec; 4(6):770-1. PubMed ID: 4476940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunology of malignant neoplasms of the urogenital system].
    Stratev S
    Khirurgiia (Sofiia); 1988; 41(1):46-52. PubMed ID: 3285081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genitourinary cancer].
    Akaza H
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):32. PubMed ID: 19195114
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy and gene therapy for genitourinary malignancies.
    Sokoloff MH; Belldegrun A
    Int J Urol; 1996 Jan; 3(1 Suppl):S4-18. PubMed ID: 24304019
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene and immune-based therapies for genitourinary malignancies: current status and future prospects.
    Zisman A; Pantuck AJ; Belldegrun A
    Isr Med Assoc J; 2000 Jan; 2(1):33-42. PubMed ID: 10892369
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy in genitourinary neoplasia.
    Droller MJ
    Urol Clin North Am; 1984 Nov; 11(4):643-57. PubMed ID: 6209844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Workshop on genitourinary cancer immunology.
    Natl Cancer Inst Monogr; 1978 Dec; (49):3-403. PubMed ID: 34798
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy and genitourinary neoplasia.
    Droller MJ
    Urol Clin North Am; 1980 Oct; 7(3):831-46. PubMed ID: 6161466
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy for Genitourinary Cancers: New Opportunities for Clinical Impact.
    Nair SS; Tewari AK
    Urol Clin North Am; 2020 Nov; 47(4):xi-xii. PubMed ID: 33008502
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte-induced angiogenesis assay--in cutaneous malignancies and cutaneous and genital warts.
    Szmurło A; Grzesik W
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):85-7. PubMed ID: 2466452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular therapeutic control and gene therapy approaches].
    Mickisch GH
    Urologe A; 1995 May; 34(3):189-94. PubMed ID: 7610510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of biomarkers in the diagnosis, prognosis and therapy of patients with immuno-oncological treatments of genito-urinary carcinomas].
    Compérat E; Eymerit C; Moroch J; Varinot J
    Aktuelle Urol; 2018 Apr; 49(2):171-177. PubMed ID: 29587322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunocompetence and immunotherapy in patients with cancer of the head and neck region].
    Vinzenz K; Micksche M
    Z Stomatol; 1986 May; 83(3):203-18. PubMed ID: 3465128
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant immunotherapy with a S. pyogenes preparation (OK432) in urogenital cancer patients.
    Nakagami Y; Chin H; Tannowa K; Matsumoto K; Kawai H
    Invest Urol; 1980 Mar; 17(5):386-9. PubMed ID: 6965669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.